ACHIEVE LIFE SCIENCES, INC. financial data

Symbol
ACHV on Nasdaq
Location
Seattle, WA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 524% % 68%
Debt-to-equity 66% % 0.18%
Return On Equity -197% % -82%
Return On Assets -118% % -81%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53,233,988 shares 55%
Common Stock, Shares, Outstanding 52,812,488 shares 54%
Entity Public Float $144,081,005 USD 59%
Common Stock, Value, Issued $121,000 USD 17%
Weighted Average Number of Shares Outstanding, Basic 51,017,662 shares 49%
Weighted Average Number of Shares Outstanding, Diluted 51,017,662 shares 49%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $26,420,000 USD 50%
General and Administrative Expense $25,919,000 USD 90%
Costs and Expenses $52,339,000 USD 67%
Nonoperating Income (Expense) $7,000 USD 100%
Net Income (Loss) Attributable to Parent $52,346,000 USD -59%
Earnings Per Share, Basic -1 USD/shares -26%
Earnings Per Share, Diluted -1 USD/shares -26%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $31,930,000 USD 235%
Marketable Securities, Current $16,184,000 USD
Cash, Cash Equivalents, and Short-term Investments $48,100,000 USD 12%
Assets, Current $50,055,000 USD 9.9%
Property, Plant and Equipment, Net $8,000 USD -38%
Operating Lease, Right-of-Use Asset $79,000 USD 295%
Goodwill $1,034,000 USD 0%
Assets $52,040,000 USD 8.6%
Accounts Payable, Current $1,943,000 USD 92%
Employee-related Liabilities, Current $2,429,000 USD 3.8%
Liabilities, Current $9,730,000 USD 45%
Operating Lease, Liability, Noncurrent $21,000 USD
Liabilities $18,425,000 USD 11%
Accumulated Other Comprehensive Income (Loss), Net of Tax $9,000 USD -88%
Retained Earnings (Accumulated Deficit) $245,564,000 USD -27%
Stockholders' Equity Attributable to Parent $33,615,000 USD 7.1%
Liabilities and Equity $52,040,000 USD 8.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $11,088,000 USD -110%
Net Cash Provided by (Used in) Financing Activities $56,110,000 USD 119283%
Net Cash Provided by (Used in) Investing Activities $11,353,000 USD
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 52,812,488 shares 54%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $263,000 USD -99%
Deferred Tax Assets, Valuation Allowance $81,830,000 USD 12%
Deferred Tax Assets, Gross $82,160,000 USD 12%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $52,412,000 USD -16%
Property, Plant and Equipment, Gross $256,000 USD 0%
Operating Lease, Liability, Current $59,000 USD 168%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards $54,553,000 USD 12%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $761,000 USD 0%
Operating Lease, Payments $52,000 USD -15%
Amortization of Intangible Assets $200,000 USD 0%
Deferred Tax Assets, Net of Valuation Allowance $330,000 USD -4.6%
Interest Expense $2,770,000 USD 6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%